Skip to Main Content (Press Enter)

Logo UNIMI
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission

Expertise & Skills
Logo UNIMI

|

Expertise & Skills

unimi.it
  • ×
  • Home
  • People
  • Projects
  • Fields
  • Units
  • Outputs
  • Third Mission
  1. Third Mission

Valutazione e monitoraggio dell'Infezione da Hpv delle patologie correlate in Donne ad elevato rischio per il cArcinoma della cervice uTErina

Project


Background




Pap screening, an effective method for cervical cancer prevention, is now supported by molecular human papillomavirus (HPV) testing. Recently commercialised preventive vaccines also provide new tools for the primary prevention of cervical cancer. To determine appropriate prevention strategies, the Health General Direction, Lombardy Region, funded a project that aims to characterize and monitor HPV infections and related cervical diseases in high-risk women.



Methods/design




VALHIDATE is a 5-year multicentre open prospective cohort study. It will recruit 7000 consenting women aged 13–65 years to provide information about the local biomolecular epidemiology of HPV infection and cervical diseases in high-risk women recruited from nine clinical centres and one faith-based organisation. The study will estimate the overall and type-specific prevalence of HPV infection and cervical abnormalities. It also aims to compare standard Pap screening with biomolecular screening, and to assist in the design of targeted regional prevention programs directed specifically at high-risk groups. Three groups of high-risk women: 1000 HIV-infected women (aged 26–65 years), 1000 recent migrant women (aged 26–65 years) and 3000 young women (aged 13–26 years) and 1 control group: 2000 women (aged 26–45 years) attending a spontaneous screening program, will be recruited. Sample sizes will be revised after the first year. Adult participants will undergo conventional cervical cytology, HPV DNA screening and genotyping. Paediatric participants will undergo HPV DNA testing and genotyping of urine samples. HPV DNA, cytological abnormalities and HPV types will be analysed according to demographic, epidemiological, behavioural, and clinical data collected in an electronic case report form. Overall and stratified prevalences will be estimated to analyse the associations between HPV infection and selected characteristics. Logistic regression models will be used to estimate crude and adjusted odds ratios. Cox proportional hazard models will be used to estimate hazard ratios over time and between groups.



Discussion/main expected results




This study will provide substantial insight into HPV infections and related cervical diseases in high-risk groups and will help determine appropriate regional cervical cancer prevention strategies.

  • Overview
  • Research Areas

Overview

Contributors

BIANCHI SILVIA   Participant  

Departments involved

Dipartimento di Scienze Biomediche per la Salute   Principale  

Type

RL_DG-WEL - Bandi DG Welfare

Date/time interval

January 1, 2015 - December 31, 2015

Project duration

12 months

Research Areas

Concepts (4)


LS6_11 - Prevention and treatment of infection by pathogens (e.g. vaccination, antibiotics, fungicide) - (2013)

LS6_8 - Virology - (2013)

LS7_9 - Public health and epidemiology - (2013)

LS8_3 - Systems evolution, biological adaptation, phylogenetics, systematics, comparative biology - (2013)

Keywords (10)

  • ascending
  • descending
ANTIPAPILLOMAVIRUS VACCINATION
CANCRO CERVICE UTERINA
CERVICAL CARCINOMA
HUMAN PAPILLOMAVIRUS
PAPILLOMAVIRUS UMANI
SALUTE DELLE DONNE
SORVEGLIANZA VIROLOGICA
VACCINAZIONE ANTIPAPILLOMAVIRUS
VIROLOGICAL SURVEILLANCE
WOMEN HEALTH
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}
  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notices

Powered by VIVO | Designed by Cineca | 26.5.1.0